undamentalytics Newsletter

Higgins John L: insider trades

Chief executive, Director at 3 companies we cover. 11 open-market purchases and 21 sales not made under a pre-set plan, reported from February 18, 2010 to November 10, 2025.

Would copying Higgins John L’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 7 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on May 9, 2012 into $69,224 by November 2, 2026, +14.3% a year. The copy held shares only 24% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $20,367, +5.0% a year (the S&P 500 held throughout made $71,597, +14.6% a year). Beta against the index was 0.42. Twelve months after each report, the average purchase was +38.1% against the S&P 500 (median +9.9%), and 57% beat it. Measured from the trade date, the insider’s own timing, the average was +46.6%. After their sales, the shares moved +1.8% against the index over 12 months on average (a negative figure means selling was the right call); 47% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$20.0k$40.0k$60.0k 20122014201620182020202220242026 $71.6k$69.2k$20.4k
Copying Higgins John LS&P 500, same days investedS&P 500, held throughout $10,000 copying Higgins John L’s open-market purchases from May 9, 2012, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+14.3%
S&P 500, same days invested
+5.0% (held throughout +14.6%)
Time in shares
24%
Sharpe ratio (S&P 500)
0.59 (0.80)
Biggest drop (S&P 500)
−51% (−34%)
Market sensitivity (beta)
0.42
Purchases copied
7

Trade by trade

Higgins John L: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 7 +1.2% −4.3% 43% 3 — — Not enough years
Purchases, 6 months after the report 7 +1.4% −13.0% 29% 3 — — Not enough years
Purchases, 12 months after the report 7 +38.1% +9.9% 57% 3 — — Not enough years
Purchases, 12 months after the trade 7 +46.6% +27.4% 57% 3 — — Not enough years
Sales, 3 months after the report 19 +0.9% −0.6% 53% 10 −0.31 0.76 No reliable evidence
Sales, 12 months after the report 19 +1.8% +0.1% 47% 10 −0.18 0.86 No reliable evidence
Sales, 12 months after the trade 19 +0.9% −0.9% 58% 10 −0.06 0.95 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Ligand Pharmaceuticals Inc LGND Chief Executive Officer811February 18, 2010September 16, 2022
Bio-Techne TECH —08September 12, 2016May 16, 2024
Omniab, Inc. OABI —32May 19, 2023November 10, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 10, 2025November 6, 2025 OABI Purchase $107,707 not yetnot yetnot yet
May 13, 2025May 12, 2025 OABI Purchase $93,600 not yetnot yetnot yet
March 20, 2025March 20, 2025 OABI Purchase $295,512 not yetnot yetnot yet
May 16, 2024May 14, 2024 TECH Sale $335,360 −16.5%−55.5%−56.4%
May 25, 2023May 23, 2023 OABI Sale $36,450 not yetnot yetnot yet
May 19, 2023May 18, 2023 OABI Sale $194,500 not yetnot yetnot yet
September 16, 2022September 15, 2022 LGND Sale $448,050 +16.9%−1.7%−4.7%
August 12, 2022August 10, 2022 TECH Sale $948,512 −0.6%−17.0%−18.7%
June 9, 2022June 7, 2022 TECH Sale $583,964 −2.7%−21.8%−18.0%
November 12, 2021November 12, 2021 LGND Sale $481,500 −20.4%−9.3%−6.6%
November 10, 2020November 6, 2020 TECH Sale $1,501,735 +19.8%+34.1%+32.2%
February 14, 2020February 12, 2020 TECH Sale $1,026,150 +41.3%+79.5%+75.4%
July 31, 2019July 31, 2019 LGND Purchase $176,582 +12.5%+9.9%+27.4%
June 6, 2019June 4, 2019 TECH Sale $1,018,350 −14.3%+7.5%+14.5%
May 31, 2019May 31, 2019 LGND Purchase $108,200 −24.5%−13.9%−18.1%
May 14, 2019May 14, 2019 LGND Purchase $283,750 −18.6%−20.1%−14.1%
March 15, 2019March 13, 2019 LGND Purchase $285,725 −13.1%−27.4%−19.2%
August 31, 2018August 30, 2018 LGND Sale $903,875 −34.1%−70.2%−68.3%
August 27, 2018August 23, 2018 TECH Sale $1,879,200 −8.9%+0.1%−0.9%
November 20, 2017November 17, 2017 LGND Sale $316,888 +12.1%+12.7%−0.4%
November 17, 2017November 16, 2017 LGND Sale $750,991 +14.0%+9.9%+1.2%
March 10, 2017March 8, 2017 LGND Sale $428,240 +4.0%+47.1%+45.3%
September 23, 2016September 22, 2016 LGND Sale $352,020 −14.3%+0.6%−2.5%
September 12, 2016September 8, 2016 TECH Sale $186,711 −6.8%−2.0%−5.3%
March 9, 2016March 7, 2016 LGND Sale $1,110,027 +11.7%−8.9%−17.1%
August 7, 2015August 6, 2015 LGND Sale $516,946 −1.9%+14.8%+10.9%
June 11, 2015June 9, 2015 LGND Sale $928,809 +6.9%+19.0%+23.3%
August 15, 2014August 15, 2014 LGND Purchase $54,970 −4.2%+57.5%+62.7%
August 20, 2013August 16, 2013 LGND Sale $428,500 +11.6%−5.3%+13.2%
December 5, 2012December 5, 2012 LGND Purchase $36,060 +14.1%+168.5%+183.4%
May 8, 2012May 4, 2012 LGND Purchase $12,040 +42.0%+92.2%+103.8%
February 18, 2010February 17, 2010 LGND Purchase $10,020 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Higgins John L traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.